Global AI Medicine Software Market Analysis of Key Players, Type, Application, Demand and Consumption By 2026 – Stock Market Vista

There are millions of them around the globe waiting for clutching on to some of the latest vital information circulating across the globe. The up-to-the-minute AI Medicine Software market report based on the growth and the development of theAI Medicine Software marketis systematically listed down. The AI Medicine Software market report comprises statistically verified facts such the unique essence including topological investigations, worldwide market share, government stringent norms, applications, current trends, futuristic plans, market bifurcations, and so on mentioned in a crystal clear pattern.

The statistical plus scientific AI Medicine Software market report has all the important market aspects penciled down in a layman language format so that the data based on the markets productivity or future strategy can be easily extrapolated from the reports. The AI Medicine Software market report has the dominant market players Tempus Labs, Inc., Flatiron Health, Inc., Gene42, Inc., Sunquest Information Systems Inc, 2bPrecise LLC, NantHealth, Inc, IBM Watson Group, Human Longevity, Inc., N-of-One, Inc., Translational Software, Inc, SOPHiA GENETICS SA, Syapse, Inc., LifeOmic Heal explained in detail.

Sample of global AI Medicine Software Market Report at::https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259#RequestSample

The essential futuristic segments such as {Machine Learning, Natural Language Processing, Others}; {Drug Discovery, Precision Medicine, Others} have also been detailed out in the AI Medicine Software market report for the clients convenience and more of vital data embracing capability. The forecast trends along with the current market status can better understand the AI Medicine Software market development on a global basis. The intricate industrial strategies and the supply-demand chain are also discussed in the contextual report.

Key points of the global AI Medicine Software market

Theoretical analysis of the global AI Medicine Software market stimulators, products, and other vital facets Recent, historical, and future trends in terms of revenue and market dynamics are reported Pin-point analysis of the competitive market dynamics and investment structure is predicted to grow Future market trends, latest innovations, and various business strategies are reported Market dynamics include growth influencers, opportunities, threats, challenges, and other crucial facets

The AI Medicine Software market report has the imperative data mentioned in a systematic way only after comprehensive inspection and vigilant referencing. The diagrammatic representations such as a pie chart of the AI Medicine Software market are also drawn out so as to attract the punters and make it easy for them to comprehend the entire AI Medicine Software market from in and out. The most eye-catching format of the AI Medicine Software market report is its market bifurcation based on the product type, application, geography, end-users, and more as per the particular market. The geographical segments Europe, North America, Latin America, Asia Pacific, and Middle East & Africa are further exhaustively mentioned.

Read Detailed Index of full Research Study at::https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259

Questions answered in the report include

1. What is the expected market size by the end of the forecast period?2. What are the major factors initiating the global AI Medicine Software market growth?3. What are the latest developments and trending market strategies that are influencing the growth of the AI Medicine Software market?4. What are the key outcomes of the AI Medicine Software market developments?5. Who are the key players in the market?6. What are the opportunities and challenges faced by the key players?

The AI Medicine Software market report endows the global market dominance, market segmentation, growth factors, and others reported such that the clients can have a total tour of the market without any much off efforts needed.

Key Reasons for Purchasing Global AI Medicine Software Market Report

New approaches and latest development trend that describe the structure of the market Advanced market breakdown structure Historical data and future market scope In-depth market analysis based on statistics, growth stimulators, and market developments Statistical data representation through figurative, numerical, and theoretical elaboration Report provides insight of the business and sales activities

Ask Any Kind of Query Before Purchasing the Report Here:https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259#InquiryForBuying

Originally posted here:
Global AI Medicine Software Market Analysis of Key Players, Type, Application, Demand and Consumption By 2026 - Stock Market Vista

Global Adrenomyeloneuropathy Treatment Market Size, Share, Trends, CAGR by Technology, Key Players, Regions, Cost, Revenue and Forecast 2020 to 2025 -…

New Market Research Report: on Adrenomyeloneuropathy Treatment Market size | Segment by Applications (Hospitals, Clinics, Ambulatory Surgical Centers and Others), by Type (Steroid Replacement Therapy and Stem Cell Transplant), Regional Outlook Opportunity, Market Demand, Latest Trends, Adrenomyeloneuropathy Treatment Industry Share & Revenue by Manufacturers, Leading Companies Profiles, Analysis, Growth Forecast 2025. Analyzes current market size and upcoming Few years' growths of this industry.

Adrenomyeloneuropathy Treatment Market Size report is the best source that gives CAGR values with variations during the forecast period of 2020-2025 for the market. The study encompasses market drivers and restraints by using SWOT analysis, along with their impact on the demand over the forecast period. This global market report endows with a profound overview of product specification, product type, production analysis, and technology by taking into consideration the major factors such as revenue, cost, and gross margin. The Adrenomyeloneuropathy Treatment advertising report has been prepared based on the market type, size of the organization, availability on-premises, and the end-users organization type.

Some of the prominent players operating in the global Adrenomyeloneuropathy Treatment market include Ascend Biopharmaceuticals, Immatics Biotechnologies, Human Longevity, Novadip Biosciences, BioRestorative Therapies, Eureka Therapeutics, Cytori Therapeutics, Allogene Therapeutics, Regeneus, NewLink Genetics and Talaris Therapeutics among others.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/240610

Competitive Analysis: Adrenomyeloneuropathy Treatment Market

Global Adrenomyeloneuropathy Treatment market Size is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Adrenomyeloneuropathy Treatment market Share for global, Europe, North America, Asia-Pacific, South America, and Middle East & Africa.

Global Adrenomyeloneuropathy Treatment Market Split by Product Type and Applications:

Based on Types:

Based on Application:

The latest research on the Adrenomyeloneuropathy Treatment Market Size fundamentally delivers insights that can empower stakeholders, business owners, and field marketing executives to make effective investment decisions driven by facts and extremely thorough research. The study aims to provide an evaluation and deliver essential information on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Adrenomyeloneuropathy Treatment Market for the forecast period, 20202025. To help firms comprehend the Adrenomyeloneuropathy Treatment industry in multiple ways, the report exhaustively assesses the share, size, and growth rate of the business worldwide.

Report Highlights:

The report covers the shifting industry dynamics

Detailed information about the market segmentation

Covers past, present and projected industry size Recent industry trends

Key Competition landscape

Business strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards market performance

Queries Resolved In This Report:

Which will be the specialties at which Adrenomyeloneuropathy Treatment Market players profiling with intensive designs, financials, and ongoing headways should set nearness?

Which will be the foreseen development rates for your own Adrenomyeloneuropathy Treatment economy out and out and each portion inside?

Which will be the Adrenomyeloneuropathy Treatment application and sorts and estimate joined intently by makers?

Which will be the dangers which will attack growth?

The length of the global Adrenomyeloneuropathy Treatment market opportunity?

How Adrenomyeloneuropathy Treatment Market share advance vacillations of their value from various assembling brands?

Chapters Define in TOC (Table of Content) of the Report:

Chapter 1: Market Survey, Drivers, Restraints and Good fortune, Segmentation overview

Chapter 2: Market competitiveness by Manufacturers

Chapter 3: Production by Regions

Chapter 4: Consumption by Regions

Chapter 5: Production, By Types, Revenue and Market share by Types

Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications

Chapter 7: Overall profiling and analysis of Manufacturers

Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses

Chapter 9: Supply Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Influence Factors Analysis

Chapter 12: Market Predict

Chapter 13: Adrenomyeloneuropathy Treatment Research Findings and Conclusion, Appendix, methodology and data source

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/240610

Continue reading here:
Global Adrenomyeloneuropathy Treatment Market Size, Share, Trends, CAGR by Technology, Key Players, Regions, Cost, Revenue and Forecast 2020 to 2025 -...

4 Reasons To Use Cannabis For Treating Women’s Health Issues – Longevity LIVE

Specific dietary changes, like including natural supplements, can help in enhancing sexual energy in women. Aphrodisiacs are the foods, drinks, or drugs that help increase female libido. Cannabis is another such natural aphrodisiac that can help increase womens libido. Cannabis can also help in reducing the pain during penetration experienced by some women.

According to a study, women who ate cannabis experienced two times higher sex drives, with satisfactory orgasms than those with irregular cannabis usage. Cannabis interacts with endocannabinoids in the body, which help regulate sexual function. Women can use cannabis as an aphrodisiac in many ways. Earlier, people used to take it in the form of a beverage, but today, there are many different consumption methods. Women can also use cannabis as lubricants, helping in reducing pain during sex.

Mental health disorders affect both men and women, but theyre more severe in women. Various factors like career, family responsibility, and abuse are significant causes of mental issues in women. The most common mental illness in women is depression, bipolar disorder, and schizophrenia, often challenging to diagnose.

According to an article, cannabis has antidepressant traits that help decrease anxiety and depression in women. The depletion of serotonin in the brain leads to depression. However, taking cannabis in low doses helps release serotonin, which causes anti-depressant effects. This can help in alleviating stress and anxiety, as well as assisting in doing day-to-day activities.

These are some of the benefits of cannabis for women. Research states that one should always use cannabis from low doses to reap the right health benefits. Buy cannabis products from reputed shops that will provide authentic cannabis products. Make sure to check the THC and CBD content in the product to understand the dosage. You may need to think twice if you have any medical condition or are taking any medication. If you fall into either of these groups, make sure to consult a health professional before starting cannabis.

Denson, T. F., & Earleywine, M. (2006). Decreased depression in marijuana users.Addictive behaviors,31(4), 738742. https://doi.org/10.1016/j.addbeh.2005.05.052

Lynn, B. K., Lpez, J. D., Miller, C., Thompson, J., & Campian, E. C. (2019). The Relationship between Marijuana Use Prior to Sex and Sexual Function in Women.Sexual medicine,7(2), 192197. https://doi.org/10.1016/j.esxm.2019.01.003

Olh, A., Tth, B. I., Borbr, I., Sugawara, K., et al. (2014). Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. The Journal of clinical investigation,124(9), 37133724. https://doi.org/10.1172/JCI64628

Read more:
4 Reasons To Use Cannabis For Treating Women's Health Issues - Longevity LIVE

US listing set to support and accelerate ongoing development of 4D Pharma’s live biotherapeutics – BioPharma-Reporter.com

The move follows the merger it announced late last month with the NASDAQ listed, Longevity, a special purpose acquisition company (SPAC). 4D Pharma will become dual-listed and ordinary shares will continue to be traded on AIM.

Live biotherapeutics, a novel class of drug derived from the microbiome,are defined by the US Food and Drug Administration (FDA) as being biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.

The merger is set to be completed and effective in early 2021, said the UK firm. But it is subject to approval by 4D Pharma and Longevity shareholders and it is also bound by the SEC review process.

The US listing is set to support and accelerate ongoing development of its live biotherapeutics, said the CEO, Duncan Peyton.

It is a big step for 4D Pharma, it is a big step for any European biotech business to step across the Atlantic and become a US listed business. It is something we have worked on for a while, he told BioPharma-Reporter.

The benefits are evident, he said. We get access to strong healthcare funds that understand innovative technologies like live biotherapeutics, we get access to more capital."

4D Pharma, which was officially founded in 2014, is at a pivotal time in its growth and development, said the CEO.

4D Pharma's live biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut, and it has developed a proprietary platform, MicroRx (R), that identifies live biotherapeutics based on a deep understanding of function and mechanism.

Its clinical programs target cancer, including a clinical collaboration with Merck, respiratory diseases such as COVID-19 and asthma, gastrointestinal diseases, and pre-clinical programs targeting neurological diseases like Parkinsons disease and auto-immune diseases. It is also engaging in a vaccine research collaborative alliance with Merck.

Peyton said that despite the operational and economic challenges in 2020 created by the global pandemic, the biotech has made significant strides on several fronts.

This includes 4D Pharma presenting clinical data for live biotherapeutics for the treatment of cancer in combination with Mercks Keytruda, as well as positive Phase II results for the first drug candidate able to treat both IBS-C and IBS-D. In addition, earlier in 2020, 4D Pharma was able to quickly instigate a Phase II clinical trial in COVID-19 based on our detailed understanding of our asthma program.

What are the big next steps, and what is the regulatory approval timeline looking like for 4D Pharmas live biotherapeutics?

That really depends on the pathway we take, in the coming weeks and months, in relation to our oncology program, in particular.

We want to expand on the data we have seen recently in relation to oncology and IBS and take that through to approval trials.

The IBS trial will probably take longer, as there is need to address a large patient population. The oncology space is slightly different, and there is [an option] to get an accelerated approval.

Product registration is within reach then. I would say we are just a couple of years, not a decade, away from approval.

4D Pharma is a leader in the field, he said. From a research point of view, we are streets ahead.

The company understands the mechanisms of action of its strains and can demonstrate that preclinically and in patients, he said.

Those capabilities are supported by nearly 1,000 granted patents. I think we have a similar number of patents in development, and all of our IP is generated in-house, our team is pushing forward mechanistic understanding.

And Mercks engagement is a validation of 4Ds clinical pipeline and research capabilities, he added.

The companys platform, he said, goes beyond just addressing diseases of the gut, to explore oncology and immune system related areas. We are also starting to understand and unpick how our bacteria actually act on the gut-brain axis, continued Peyton.

Such insights could potentially lead to innovation in the neurodegenerative disease field, he said.

And the CEO sees Big Pharma's attitudes to the live biotherapeutics field changing.

We have been working with Merck, who I believe to be one of the most innovative of Big Pharma companies, for the past two and half years. We have been working with them on Keytruda, which is probably the biggest selling drug in the world right now, we are looking at how we can expand the patient groups into which Keytruda is active or regenerate a response for the drug, as it does not work in all patients. That is a signal of Mercks belief in the microbiome.

On top of that, Merck asked us to explore what we could do for it in relation to its vaccine business. We have that vaccine program [set up] now, we are doing all the research, and Merck will take it on from the preclinical stage.

As we publish more data on oncology and IBS, we are getting more incoming calls.

The landscape continues to change, some Big Pharma companies want to wait and see, others want to get involved and Merck is one of those.

4D Pharma has six clinical programs, namely a Phase I/II study of MRx0518 in combination with Keytruda (pembrolizumab) in solid tumors, a Phase I study of MRx0518 in a neoadjuvant setting for patients with solid tumors, a Phase I study of MRx0518 in patients with pancreatic cancer, a Phase I/II study of MRx-4DP0004 in asthma, a Phase II study of MRx-4DP0004 in patients hospitalized with COVID-19, and Blautix (R) in Irritable Bowel Syndrome (IBS) which has completed a successful Phase II trial.

Preclinical stage program include candidates for CNS disease such as Parkinson's disease and other neurodegenerative conditions.

Read the original here:
US listing set to support and accelerate ongoing development of 4D Pharma's live biotherapeutics - BioPharma-Reporter.com

What’s Wrong With Health Care in the United States? – Psychiatric Times

Health care in the United States is in poor health, its quality steadily declining since the 1960s. According to the World Economic Forum , in the 1950s the United States ranked first among the developed nations in the quality of health care. But now, despite enlisting renowned physicians, public health experts, economists, business leaders, and specialists in the treatment of ailing systems, we rank near the bottom.

What is the explanation? Is something being overlooked in the current effort to improve medical care? Do we not understand the cause of this fatal condition? The authors believe it is the importance of relationships that is being ignored; the physician-patient relationship, family relationships, and relationship systems in the community. Four key elements in our current health care system are responsible for this failure to acknowledge these critical relationships.

Interchangeability of parts

The foundation of the Industrial Revolution was the ability to create interchangeable parts. For example, workers on an assembly line build excellent automobiles cost-effectively. Health care administrators are using that model in medicine. The model of industrialized medicine works poorly when dealing with human beings, and is cost-effective only in the short run. Patients and practitioners are not interchangeable parts. Patients and their illnesses are too complex for a one-size-fits-all design. A health care model that does not recognize each patient as a unique person existing in a unique network of relationshipswith medical practitioners, family, and communityresults in increasingly poor outcomes, as the data demonstrate.

Systematic ignoring of the physician-patient and physician-family relationships

Treatment outcomes decline when patients see a different physician at each visit. The industrialized model excludes the importance of relatedness between physician and patient, losing the stabilizing relational linkages. For example, patients in hospitals cared for by their primary care physician are more likely to be discharged home and less likely to die within 30 days than those cared for by hospitalists who do not have an ongoing relationship with the patient and family.

The lack of sustained relationships between physicians and patients, and physicians and families, in the context of their community, impairs the effectiveness of treatment. It is costly to the physicians sense that their work is meaningful, and thus costly to physician morale. Systems that fail to attend to the physician-patient relationship lead to decreased treatment effectiveness, physician burnout, early retirement, and increased rates of physician suicide.

Healing is more likely in the context of families than healing in isolation

Without attention to context, our words, actions, and experience have no meaning. Family and community relationships are the context of our patients lives. Strong social connections are associated with increased longevity. For example, marriage is a protective factor against cardiac disease and the death of a spouse is associated with increased rates of physical illness in the surviving spouse. For individuals with a chronic illness, treatment without consideration of family and community appears simpler and more efficient, but leads to sterile, out-of-context, uninformed treatment, blinding both the patient and the physician from seeing both the illness and the solution.

The undermining and erosion of family and community

Regulations and reimbursement systems that reduce the medical interaction to a specific procedure diminish the involvement of families and communities in a patients recovery. The Health Information Portability and Accountability Act (HIPAA), for example, which was established to protect patient confidentiality, immediately became an obstacle to communication with the people in the patients life who can help with follow-up appointments, medication adherence, continuity of care, and emotional support.

Treating the correct condition

The 4 elements described point to both the fatal condition and its solution. Attention to the whole person, focusing on relationships with physicians and nurses, patients and families, and the web of community relationships available in every community to every patient, helps people get and stay healthy. Any potential solution to the health care system that ignores relationships will always be ineffective. If industrial medicine worked, and at this point weve done that experiment, costs would not be rising, patients and physicians would not be dissatisfied, and health would be improving.

Dr Copansis Adjunct Associate Professor, Geisel School of Medicine at Dartmouth, Hanover, NH.Dr Rahmaniis training director of Child and Adolescent Psychiatry at the University of Florida.

*Members of the Research Committee, Group for the Advancement of Psychiatry also include Dr John Beahrs, Emeritus Professor of Psychiatry, Oregon Health and Science University, Portland; Dr Allan Josephson, (Former) Professor and Chief, Division of Child and Adolescent Psychiatry, University of Louisville School of Medicine; Dr David Keith, Professor Emeritus, Department of Psychiatry and Behavioral Sciences, Upstate Medical Center, Syracuse, NY; Dr Patrick Malone (19442016); Dr Alan Swann, Professor of Psychiatry, Baylor College of Medicine, and staff psychiatrist, Houston VA Medical Center; Dr William Swift, Emeritus Clinical Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison; Dr Johan Verhulst (19382019); and Dr Douglas Kramer, Emeritus Clinical Professor of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, and Chair, GAP Research Committee.

Continue reading here:
What's Wrong With Health Care in the United States? - Psychiatric Times

4D Pharma to host virtual KOL event reviewing new data presented at the Society for Immunotherapy of Cancer annual meeting 2020 from Live Biotherapeut…

4D Pharma to host virtual KOL event reviewing new data presented at the Society for Immunotherapy of Cancer annual meeting 2020 from Live Biotherapeutic MRx0518 clinical programs

Leeds, UK, November 5, 2020, 4D pharma plc(AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces that it will host a virtual Key Opinion Leader (KOL) event to review data presented from two ongoing clinical trials of MRx0518, the Companys lead immuno-oncology single strain Live Biotherapeutic, as both a neoadjuvant monotherapy and combination therapy in patients refractory to checkpoint inhibitors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020. The event will take place on Wednesday, November 11, 2020 at 1:00pm GMT (8:00am ET).

The event will feature presentations from 4D pharma management and KOLs, Dr Mark P Lythgoe, Academic Clinical Fellow in Medical Oncology and Pharmacist at Imperial College London, and Dr Shubham Pant, Associate Professor Department of Investigational Cancer Therapeutics and Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center.

A live webcast of the event will be available on the Reports and Presentations section of the 4D Pharma website atwww.4dpharmaplc.com. To access the call, please dial 1-877-270-2148 (United States) or 1-412-902-6510 (international) and reference the 4D pharma conference call to join. A replay of the webcast and accompanying slides will be available on the 4D pharma website following the event.

About 4D pharma

Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx(R), that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.

4D pharma's Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut.The Company has six clinical programmes, namely a Phase I/II study of MRx0518 in combination with KEYTRUDA (pembrolizumab) in solid tumours, a Phase I study of MRx0518 in a neoadjuvant setting for patients with solid tumours, a Phase I study of MRx0518 in patients with pancreatic cancer, a Phase I/II study of MRx-4DP0004 in asthma, a Phase II study of MRx-4DP0004 in patients hospitalised with COVID-19, and Blautix(R) in Irritable Bowel Syndrome (IBS) which has completed a successful Phase II trial. Preclinical-stage programmes include candidates for CNS disease such as Parkinson's disease and other neurodegenerative conditions. The Company has a research collaboration with MSD, a tradename of Merck & Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics for vaccines.

In October 2020 4D pharma announced its intention to merge with Longevity Acquisition Corporation (NASDAQ: LOAC), a special purpose acquisition company (SPAC), and seek a NASDAQ listing.The merger is expected to be completed and the NASDAQ listing of 4D pharma American Depositary Shares (ADSs) under the ticker symbol LBPS is currently expected to become effective in early 2021, subject to approval of 4D Shareholders and Longevity Shareholders, and the SEC review process.

For more information, refer tohttps://www.4dpharmaplc.com

Here is the original post:
4D Pharma to host virtual KOL event reviewing new data presented at the Society for Immunotherapy of Cancer annual meeting 2020 from Live Biotherapeut...

Global Testosterone Replacement Therapy Market Growth, Development Strategy, Trends, Demand, Future Prospects and Forecast to 2024 – PRnews Leader

The Testosterone Replacement Therapy Market study describes the current market size and market forecast, market prospects, main drivers and constraints, regulatory scenario, industry trend, PESTLE analysis, PORTER analysis, new product approvals / launch, promotion and marketing campaigns, pricing analysis , competitive environment to assist companies in decision-making. The data from the study is focused on current and historical market dynamics that assist in decisions related to investment.

Testosterone Replacement Therapy offers fundamental industry overview representing market trends, company profiles, growth drivers, market scope and Testosterone Replacement Therapy size estimation. The valuable Testosterone Replacement Therapy industry insights, type, application, deployment status and research regions are studied. A thorough analysis of gross margin view, trade news, industry plans and policies, constraints are explained. A complete Testosterone Replacement Therapy industry scenario is explained from 2014 to 2019 and forecast estimates are presented from 2020-2024. The productions, industry chain analysis, gross margin structure and deployment models are stated in detail. Top regions analysed in the report include North America, South America, Europe, Asia-Pacific, Middle East & Africa and the rest of the world. The Testosterone Replacement Therapy industry presence and maturity analysis will lead to investment feasibility and development scope.

Get A Free Sample Copy Here:

https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#request_sample

Testosterone Replacement Therapy Market Leading Players (2019-2024):

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Market Segment Analysis

By Types:

GelsInjectionsPatchesOther

By Applications:

HospitalsClinicsOthers

By Region

North America

Europe

Asia-Pacific

LAMEA

Ask for Discount @:

https://www.globalmarketers.biz/discount_inquiry/discount/129647

Testosterone Replacement Therapy Industry Report addresses different regions like North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. The production value, gross margin analysis, development trend, and Testosterone Replacement Therapy market positioning is explained. The industrial chain study, potential buyers, distributors and traders details are explained. The challenges to the growth and market restraints are explained. The market maturity study, investment scope and gross margin study are profiled. The production process structure, market share, manufacturing cost and Testosterone Replacement Therapy saturation analysis is covered. This will helps the industry aspirants to analysis growth feasibility and development plans.

A special highlight on cost structure, import-export scenario and sales channels of Testosterone Replacement Therapy industry is presented. The benchmarking products, dynamic market changes, upstream raw material and downstream buyers analysis are presented. The business trends, key players analysis and product segment study are explained. The regional SWOT analysis, gross margin analysis, application analysis and industry barriers are explained. The value, volume and consumption from 2019-2024 is portrayed. All the essential details like pricing structure of raw materials, labour cost, sales channels and downstream buyers are presented.

Inquire Before Buying Or Ask For Custom Requirement:

https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#inquiry_before_buying

In the next segment, the forecast Testosterone Replacement Therapy industry perspective is covered. Under forecast statistics, the market value, volume and consumption forecast from 2019-2024 is explained. Testosterone Replacement Therapy regional analysis for major regions and countries in this region is stated. The study of new Testosterone Replacement Therapy industry aspirants and analysts opinions for this industry is presented. The limitations to the industry growth, market risks, Testosterone Replacement Therapy growth opportunities and market trends are viewed. The revenue, Testosterone Replacement Therapy market status, past market performance and product details are presented.

Salient Features Of The Report:

The Testosterone Replacement Therapy report serves as a vital guide in portraying present and forecast industry statistics and market size. The supply/ demand situation, gross margin view and competitive profile of top Testosterone Replacement Therapy players are presented. The Testosterone Replacement Therapy market breakdown by product, type, application and regions will provide sophisticated and precise analysis. Recent developments in Testosterone Replacement Therapy industry, growth opportunities, constraints are studied completely. Also, new product launch events, mergers & acquisitions of Testosterone Replacement Therapy , and industry plans and policies are covered.

The revenue estimates of Testosterone Replacement Therapy market based on top industry players, their product type, applications and regions is studied. The cost structures, gross margin view, sales channel analysis and value chain is explained. In the next segment, the SWOT analysis of players, cost structures, traders, distributors and dealers are listed. The forecast study on Testosterone Replacement Therapy industry will be useful for business plans and growth analysis.

To know More Details About Testosterone Replacement Therapy Market research Report @:

https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

See original here:
Global Testosterone Replacement Therapy Market Growth, Development Strategy, Trends, Demand, Future Prospects and Forecast to 2024 - PRnews Leader

Testosterone Replacement Therapy Market Size, Trends and Cost with Global Forecast by 2027 – Eurowire

Testosterone Replacement Therapy Market Size And Forecast

A comprehensive overview of the Testosterone Replacement Therapy Market is recently added by Market Research Intellect to its humongous database. Furthermore, the Testosterone Replacement Therapy Market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, this innovative report makes use of SWOT, PESTLE, and Porters Five Forces analyses to get a closer outlook on the Testosterone Replacement Therapy Market. Furthermore, the Testosterone Replacement Therapy Market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Testosterone Replacement Therapy Market at the global and regional levels. The study covers the impact of various drivers and manacles on the Testosterone Replacement Therapy Market growth opportunities over the forecast period.

Impact of Covid-19 :

During the first quarter of 2020, different global economies were badly impacted by a viral outbreak of COVID-19. This viral outbreak of the Covid-19 was later recognized as a global pandemic by the World Health Organization (WHO). COVID-19 spread in different global countries, affecting a large number of people in a short timeframe. The outburst of COVID-19 adversely hit different global economies in the world. The stringent regulations imposed by several governments, including complete lockdown and quarantine methodologies to fight against COVID-19, resulted in a massive impact on various business sectors. We at Market Research Intellect offer an informative report on the Testosterone Replacement Therapy Market which helps in making strategic decisions over the forecast period.

Competitive Landscape:

The degree of competition among leading global companies has been elaborated by examining various leading key players operating across the global regions An expert team of research analysts sheds light on various attributes such as -global market competition, market share, latest industry developments, innovative product launches, partnerships, mergers or acquisitions by leading companies in the Testosterone Replacement Therapy Market. The leading manufacturers have been analyzed by using research methodologies for getting insight views on global competition.

Following key players have been profiled with the help of proven research methodologies:

The Testosterone Replacement Therapy Market has been examined into different global market segments such as type, applications and global geographies. Each and every global market segment has been studied to get informative insights into various global regions.

Testosterone Replacement Therapy Market Segmentation:

Testosterone Replacement Therapy Market Segment by Type:

Testosterone Replacement Therapy Market Segment by Application:

Testosterone Replacement Therapy Market Segment by Global Presence:

North America Latin America Middle East Asia-Pacific Africa Europe

The report has been aggregated by using a couple of research methodologies such as primary and secondary research techniques. It helps in collecting informative pieces of professional information for deriving effective insights into the market. This informative report helps in making well informed and strategic decisions throughout the forecast period.

Key questions answered through this analytical market research report include:

What are the latest trends, new patterns and technological advancements in the Testosterone Replacement Therapy Market? Which factors are influencing the Testosterone Replacement Therapy Market over the forecast period? What are the global challenges, threats and risks in the Testosterone Replacement Therapy Market? Which factors are propelling and restraining the Testosterone Replacement Therapy Market? What are the demanding global regions of the Testosterone Replacement Therapy Market? What will be the global market size over the coming future? What are the different effective business strategies followed by global companies?

If you have any custom requirements, please let us know and we will offer you the customized report as per your requirements.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Website https://www.marketresearchintellect.com/

Read the original post:
Testosterone Replacement Therapy Market Size, Trends and Cost with Global Forecast by 2027 - Eurowire

Testosterone Replacement Therapy Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to 2020 …

A recent market research report added to repository of Credible Markets is an in-depth analysis of Global Testosterone Replacement Therapy Market. On the basis of historic growth analysis and current scenario of Testosterone Replacement Therapy market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Testosterone Replacement Therapy market.

This report examines all the key factors influencing growth of global Testosterone Replacement Therapy market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Testosterone Replacement Therapy market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.

Download FREE Sample Copy of Testosterone Replacement Therapy Market Report @https://www.crediblemarkets.com/sample-request/testosterone-replacement-therapy-market-843190

Market Leaders mentioned in our report, with in-depth analysis

Endo InternationalAbbVieEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Market by Type

GelsInjectionsPatchesOthers

Market by Application

HospitalsClinicsOthers

By Region

Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]

Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

North America[United States, Canada, Mexico]

Middle East & Africa[GCC, North Africa, South Africa]

South America[Brazil, Argentina, Columbia, Chile, Peru]

Direct Purchase Testosterone Replacement Therapy Market Research Report Now @https://www.crediblemarkets.com/reports/purchase/testosterone-replacement-therapy-market-843190?license_type=single_user

Some Points from Table of Content

Global Testosterone Replacement Therapy Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Chapter 1 Market Overview

Chapter 2 Key Companies

Chapter 3 Global Market Status and Future Forecast

Chapter 4 Asia-Pacific Market Status and Future Forecast

Chapter 5 Europe Market Status and Future Forecast

Chapter 6 North America Market Status and Future Forecast

Chapter 7 South America Market Status and Future Forecast

Chapter 8 Middle East & Africa Market Status and Future Forecast

Chapter 9 Market Features

9.1 Product Features

9.2 Price Features

9.3 Channel Features

9.4 Purchasing Features

Chapter 10 Investment Opportunity

10.1 Regional Investment Opportunity

10.2 Industry Investment Opportunity

Chapter 11 Coronavirus Impact

11.1 Impact on Industry Upstream

11.2 Impact on Industry Downstream

11.3 Impact on Industry Channels

11.4 Impact on Industry Competition

11.5 Impact on Industry Obtain Employment

Chapter 12 Conclusion

Contact for Any Query or Get Customized Report @ https://www.crediblemarkets.com/enquire-request/testosterone-replacement-therapy-market-843190

Points Covered in the Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 12 years data history and forecast.

The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Impact of Covid-19 in Testosterone Replacement Therapy Market:Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Testosterone Replacement Therapy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Browse the Short Summary & TOC of the Report @https://www.crediblemarkets.com/reports/testosterone-replacement-therapy-market-843190

Contact Us

Credible Markets Analytics

99 Wall Street 2124 New York, NY 10005

US Contact No: +1(929)-450-2887

Email: [emailprotected]

Thanks for reading this article you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.

Original post:
Testosterone Replacement Therapy Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to 2020 ...

Testosterone Replacement Therapy Market Report Business Scenario and Future Growth Analysis – The Courier

Data Bridge Market Research has recently published the Global research Report TitledTestosterone Replacement Therapy Market.

TheTestosterone Replacement Therapy Marketreport gives acquaintance about all the recent developments, product launches, joint ventures, mergers and acquisitions by several key players and brands while also giving a synopsis of market definition, classifications, and market trends. It lends a hand to companies to take decisive actions to deal with threats in a niche market. This market research report also provides thorough information about target markets or customers. Global Testosterone Replacement Therapy Market report is a sure-fire solution that businesses can adopt to thrive in this swiftly changing marketplace. For outstanding business growth, companies must take upmarket research report service which has become enough vital in todays market place.

This report examines all the key factors influencing the growth of Testosterone Replacement Therapy market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of Testosterone Replacement Therapy market unlocks a plethora of untapped opportunities in regional and domestic marketplaces. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, the scope of NPD in new markets, pricing strategies, innovation possibilities and much more.

Apply Free Sample PDF (including COVID19 Impact Analysis) of Testosterone Replacement Therapy MarketReport@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-testosterone-replacement-therapy-market

The Global Testosterone Replacement Therapy Market research report assembles data collected from different regulatory organizations to assess the growth of the segments. In addition, the study also appraises the global Testosterone Replacement Therapy market on the basis of topography. It reviews the macro- and microeconomic features influencing the growth of the Testosterone Replacement Therapy Market in each region. Various methodological tools are used to analyze the growth of the worldwide Testosterone Replacement Therapy market.

Prominent Key Players Covered in the report:

AbbVie Inc., Bausch Health Companies Inc., Allergan, Amneal Pharmaceuticals LLC, Pfizer Inc., Endo International plc, Teva Pharmaceutical Industries Ltd., Perrigo Company plc, Cipla Inc., Lupin, Novartis AG, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC, among others.

Major Regions as Follows:

North America (USA, Canada and Mexico)

Europe (Germany, France, the United Kingdom, Netherlands, Russia , Italy and Rest of Europe)

Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia, rest of countries etc.)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Nigeria and South Africa)

A complete value chain of the global Testosterone Replacement Therapy market is presented in the research report. It is associated with the review of the downstream and upstream components of the Testosterone Replacement Therapy Market. The market is bifurcated on the basis of the categories of products and customer application segments. The market analysis demonstrates the expansion of each segment of the global Testosterone Replacement Therapy market. The research report assists the user in taking a decisive step that will be a milestone in developing and expanding their businesses in the global Testosterone Replacement Therapy market.

Get Table Of Contents of This Premium Research For Free: https://www.databridgemarketresearch.com/toc/?dbmr=global-testosterone-replacement-therapy-market

How Does This Market Insights Help?

Key Pointers Covered in the Testosterone Replacement Therapy Market Industry Trends and Forecast

Reasons to Purchase this Report

Get Free Sample Copy of the Report to Understand the Structure of the Complete Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-testosterone-replacement-therapy-market

Market Dynamics:The Testosterone Replacement Therapy report also demonstrates the scope of the various commercial possibilities over the coming years and the positive revenue forecasts in the years ahead. It also studies the key markets and mentions the various regions i.e. the geographical spread of the industry.

TABLE OF CONTENTS

Part 01:Executive Summary

Part 02:Scope of the Report

Part 03:Research Methodology

Part 04:Market Landscape

Part 05:Pipeline Analysis

Pipeline Analysis

Part 06:Market Sizing

Market Definition

Market Sizing

Market Size And Forecast

Part 07:Five Forces Analysis

Bargaining Power Of Buyers

Bargaining Power Of Suppliers

Threat Of New Entrants

Threat Of Substitutes

Threat Of Rivalry

Market Condition

Part 08:Market Segmentation

Segmentation

Comparison

Market Opportunity

Part 09:Customer Landscape

Part 10:Regional Landscape

Part 11:Decision Framework

Part 12:Drivers and Challenges

Market Drivers

Market Challenges

Part 13:Market Trends

Part 14:Vendor Landscape

Part 15:Vendor Analysis

Vendors Covered

Vendor Classification

Market Positioning Of Vendors

Part 16:Appendix

In conclusion, the Testosterone Replacement Therapy Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report givesinformation such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation.

Get Enquiry About This Comprehensive Report: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-testosterone-replacement-therapy-market

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Customization of the Report:

Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process.

Contact:

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Originally posted here:
Testosterone Replacement Therapy Market Report Business Scenario and Future Growth Analysis - The Courier

Prison Is Even Worse When You Have a Disability Like Autism – The Marshall Project

When Drew Harrison was in prison, just sitting in his cell overloaded his senses. To dim the fluorescent lights, he covered the bulbs with toothpaste or paper. To mask overwhelming odors, he wrapped his uniform around his head.

Once, when he asked to stay longer in the prison yard, Harrison, who has autism, said he was told he was being insubordinate and was put in restrictive housing. Another time, he said he requested placement in solitary confinement so he wouldnt have to interact with people, which he found stressful.

After two and a half years, Harrison, who had been convicted of sexually assaulting an ex-girlfriend, thought he would get out more than a month early from Greensville Correction Center in Virginia, because of good behavior. But because he had failed to sign up for a job while incarcerated earlier at another Virginia prison, he had forfeited his chance at early release, according to documentation from the Virginia Department of Corrections.

Harrisons autism made it difficult for him to grasp the rules, his mother, Judy Harrison, explained. Only after she lobbied a Virginia state legislator was her sons good time reinstated; he was released in 2019. I dont know how someone with Drews diagnosis would have survived in prison without an advocate, she said. You cant teach someone not to have autism.

The prison environmentwith its loud, unpredictable noises, bright lights, unpleasant odors, complicated social dynamics and often byzantine bureaucracywould be difficult for anyone to navigate, but experts say that its particularly challenging for autistic people and people with similar disabilities.

The Americans with Disabilities Actsigned into law 30 years ago this summermandates that people with physical and developmental disorders receive equal access to programs and services provided by public institutions, including correctional facilities. But advocates for people with developmental disabilities have long argued that all too often, prisons do not fulfill that promise.

One reason may be that many states dont adequately identify prisoners with developmental disorders. The Marshall Project sent questions to all 50 state corrections departments asking whether and how they screen prisoners for developmental or intellectual disabilities. Of the 38 agencies that responded, 25 reported using screening protocols that several mental health and legal experts said dont meet professional standards. Five states said they dont screen for developmental disabilities at all.

When developmentally disabled prisoners go unidentified, they are even less likely to receive services they are entitled to under federal lawsuch as help understanding prison rules or obtaining medications. That loss of assistance leaves them vulnerable to medical misdiagnosis, isolation in solitary confinement, denial of legal and educational opportunities, sexual abuse and bullying, prisoner advocates and relatives say.

It mirrors or echoes what goes on in society. People with disabilities are often hidden and not seen, said Susan Politt, a supervising attorney at Disability Rights North Carolina, an advocacy agency. But behind bars, the situation can be even more dire. They get out in worse condition than when they go in, she said.

Experts say that incarcerated people of color with intellectual and developmental disabilities are affected disproportionately because they are less likely than their White counterparts to be diagnosed before they enter prison.

Developmental disability is an umbrella term for a group of disorders that start during childhood and restrict ones ability to learn, speak, behave or physically develop; they include autism, cerebral palsy and language and speech disorders. The most common type is intellectual disability. It is generally accepted that 2 to 3 percent of people around the world have an intellectual disability, said Maggie Nygren, executive director of American Association on Intellectual and Developmental Disabilities.

The proportion of people with developmental disabilities behind bars is likely to be higher than in the general population, research suggests. The Arc, a nonprofit that advocates for people with disabilities, estimates that between 4 and 10 percent of U.S. prisoners have an intellectual disability, a range supported by recent literature. In 2015, the Bureau of Justice Statistics reported that about 20 percent of prisoners mentioned having a cognitive disability, a category that includes developmental disability.

But when The Marshall Project contacted state corrections departments, only four of the 25 states that shared their 2019 numbers reported that the population of prisoners with developmental or intellectual disabilities was in that range. The other 21 states that shared their population numbers said that prisoners with developmental disabilities made up less than 4 percent of the total prison population.

One disability rights lawyer characterized those low numbers as implausible. Theres no rational basis under which a prison population should have a lower percentage than a general population, said Bill Van Der Pol, a senior staff attorney at the Alabama Disabilities Advocacy Project, who won a class-action lawsuit in 2014 on behalf of physically and developmentally disabled prisoners.

Thirteen states told The Marshall Project that they did not track the population numbers or could not provide them.

Many states are using screening protocols that medical and legal experts say are below professional standards. An exam should assess a persons intellect, capacity to participate in daily activities and the age at which their condition began, said Nygren. But 11 states said they either did not check for those three diagnostic points or didnt test for intellectual ability at all.

Several states said they rely primarily on an IQ test as a screening tool. In North Carolina, prisoners take an IQ test in a group upon entering the system. If they get a score of 70 or lessthe states cutoff for intellectual disabilityprisoners take the exam again. But this process prevents people with intellectual disability from being identified because it fosters familiarity with the exam, often resulting in higher scores, said John Schwade, a former prison psychologist in North Carolina who retired in 2016. Representatives from the North Carolina Department of Public Safety said that 1.8 percent of prisoners in 2019 tested with an IQ of 70 or less, well below the expected percentage.

According to a document obtained by The Marshall Project, one prisoner scored 60 on the states IQ test when first taking it, suggesting a serious intellectual disability. But after sitting for the same test again a few days later, the prisoner scored 83, which is in the normal range.

The screenings for intellectual disability are not designed to identify and provide help to inmates, but instead to exclude as many inmates as possible from receiving the help they need, Schwade wrote in an email. The consequence for disabled prisoners in the state has been a total failure to accommodate and protect, said Politt from Disability Rights North Carolina.

John Bull, the communications officer for prisons at the North Carolina Department of Public Safety, said the states strategy allows officials to quickly identify prisoners with disabilities without wasting time on those who dont need extra help. Prisons are very short-staffed, he said.

Of the other states that test prisoners during screening, eightMassachusetts, South Dakota, North Dakota, New Hampshire, Iowa, Texas, Utah, and Idahosaid they use the Test of Adult Basic Education, which is designed to evaluate academic achievement, not IQ. Experts say the exam could give hints about a persons disability, but it isnt designed to identify developmental disabilities.

Officials in five other statesKentucky, Maine, Virginia, New Mexico, and Delawaresaid their agencies dont use a test to screen prisoners for developmental disorders. In Kentucky and Virginia, officials said they typically leave it up to prisoners to tell the staff about their own disabilities. In Maine, for the most part clinicians estimate a general intellectual level of below average, average or above average, the deputy commissioner of corrections said. In New Mexico and Delaware, officials said they rely on medical and educational records to identify people who were diagnosed with a disability or participated in special education programming before entering the prison system.

Anne Morel, whose 37-year-old son David is serving time in Louisiana for possession of child pornography, said prison officials have no clue that he is mentally challenged. David was first diagnosed with intellectual disability at age 6, she said. At 25, he was told he had an IQ of 63.

David often gets scammed, his mother said, by prisoners who persuade him to buy them things with the money she gives him for food. She also believes that her son has been taken advantage of sexually. Anything anyone would tell him, Morel said, he would just do.

Autistic people and people with intellectual disability often have difficulty understanding prison rules and norms, making them especially vulnerable to exploitation in prison, says Jamelia Morgan, an associate professor at the University of Connecticut School of Law. Theres disproportionate exposure to violence, sexual or otherwise, she added.

Some parents of incarcerated people with developmental disorders say they feel powerless to help their children cope behind bars.

Gary Glissman of Nebraska said that when his adult son, Michael, spent three months in an Omaha jail for theft, he submitted medical documentation to health officials demonstrating that Michael had a clinical need for testosterone replacement therapy and psychological counseling.

Michael suffers from depression and anxiety related to Klinefelter Syndrome, a genetic developmental disability that can lead to abnormally low levels of testosterone and difficulty controlling emotions in moments of stress.

Glissman says he wasnt surprised that officials werent responsive. Its very basic in the prison system, he said. Either its broken or bleeding, or too bad.

Correction: A previous version of this story misstated the Virginia state prison where Drew Harrison was incarcerated when he learned that he was no longer eligible for early release.

Read the original here:
Prison Is Even Worse When You Have a Disability Like Autism - The Marshall Project

The Male Menopause Treatment market to substantiate from 2019 to 2029 – TechnoWeekly

Male menopause refers to the hormonal imbalance or hormonal changes in the males due to which there is a reduction in the testosterone levels in the males. There are various symptoms of male menopause. Some of the symptoms include low energy, increasing body fat, decreasing bone density, erectile dysfunction, infertility, etc. There are many other changes associated with the testosterone level changes. Some of the major changes observed in males are a growth of the muscle mass, lowering of voice and changes related to sexual functioning. The male menopause can be treated by changing the lifestyle habits or it can be treated by taking testosterone replacement therapy. Healthy lifestyle habits such as taking a healthy diet. Having proper nap etc. can treat the male menopause treatment market.

Increasing research and developmental activities is one of the major factor driving the growth of male menopause treatment market. The rate of smoking is increasing, which can lead to hormonal imbalance, increasing the growth of the male menopause treatment market. Large intake of drugs and alcohol is another important factor, which can be responsible for the reduction of testosterone level and is expected to increase the growth of male menopause treatment market. Increasing adoption of poor lifestyle habits such as a high intake of junk food, lack of exercise, etc. can be responsible for increasing the growth of male menopause treatment market. Increasing stress due to daily hectic routine can also increase the growth of male menopause treatment market. Other factors, such as increasing healthcare awareness, technological advancements leading to better diagnostic rates, increasing disposable income, modernization of the Indian society, etc. can be responsible for the significant growth of male menopause treatment market.

There are various side effects of male menopause treatment drugs, which can hinder the growth of male menopause treatment market. Lack of awareness in some of the developing regions can restrain the growth of male menopause treatment market.

To remain ahead of your competitors, request for a sample[emailprotected]

https://www.persistencemarketresearch.com/samples/28771

The global Male Menopause Treatment market is segmented on basis of drug type, Source of administration, distribution channel and geographic region:

Based on the drug type, the Male Menopause Treatment has been divided into testosterone supplements and vitamin supplements. Testosterone supplements can be given in various forms and are expected to hold the largest revenue share in the male menopause treatment market. Testosterone replacement therapy is the most common therapy, used for the treatment of male menopause treatment market. Amongst all the testosterone supplements, DHEA and D-Aspartic acid are expected to hold the maximum revenue share in the male menopause treatment market. Based on the route of administration, the male menopause treatment market has been divided into oral administration and subcutaneous administration. Oral route of administration is expected to hold the maximum revenue share in the male menopause treatment market as it is the most common form of administration used by the male patients. Based on the distribution channel, the male menopause treatment has been divided into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Drug stores and hospital pharmacies are expected to hold the maximum revenue share in the male menopause treatment market.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/28771

On the basis of geography, the global Male Menopause Treatment market is studied and divided into a few key regions such as North America, Latin America, Europe, Asia, Middle East & Africa and Oceania. North America is expected to hold a large revenue share in global Male Menopause Treatment market because of the presence of a large number of research and developmental activities and availability of technological advancement in the field of healthcare. Europe is expected to hold the second largest market share because of the presence of the large population. The Asia Pacific can also show a large revenue share in the Male Menopause Treatment market because of the increasing healthcare awareness

There are many companies manufacturing Male Menopause Treatment drugs. Some of the big pharmaceutical companies involved in the manufacture of Male Menopause Treatment drugs are Thermofisher Scientific Inc., Abbott, Sun Pharmaceuticals Industries Ltd., Perrigo Company plc, Bayer AG and many other companies.

You Can Request for TOC[emailprotected]

https://www.persistencemarketresearch.com/toc/28771

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

Visit link:
The Male Menopause Treatment market to substantiate from 2019 to 2029 - TechnoWeekly

Daniel Sokol on William Osler’s legacy and medical ethics – The BMJ – The BMJ

This is a version of a lecture given to the Osler Club of London and the British Society for the History of Medicine on 1st October 2020 as part of an online conference to celebrate the legacy of Sir William Osler 100 years on from his death in 1919.

Im a medical ethicist and a lawyer specialising in clinical negligence. I want to tell you about a recent client of mine, whom I shall call Mr T.

Mr T has given me permission to tell his story.

When I first came across Mr T a few years ago, he was 62. He lived alone and suffered from depression. He had a difficult life, plagued by an abusive father, homelessness, alcoholism, long term unemployment, relationship and behavioural problems, anxiety, and depression.

A few months before our meeting, Mr T had asked for his medical records as part of an application to move into a new council flat. As he went through his records, he found a letter, dated 20th August 1968. He was 13 at the time. The letter was written by a surgical registrar and addressed to his GP. It read as follows:

20th August 1968

Dear Dr,

This is a very curious state of affairs. Mr [Consultant Surgeon] thought this lad looked a bit odd when he came in for his bilateral orchidopexy and we arranged for him to have a buccal smear. []

Shortly after the operation we were informed that he is, in fact, a nuclear female, probably a Klinefelter, though this is by no means confirmed yet. []

We had a discussion about this and I would have thought it probably best to say nothing to the parents or the patient at this stage as it can only lead to needless worry about an untreatable condition.

When Mr T read this, he had never heard of Klinefelters but wondered whether this could explain why his body had no hair (he had never gone through puberty). Why he had breasts and feminine features? Why he had a micropenis? Why he was picked on at school and beaten by his father, who forced him to take up boxing to man up.

Is this why he suffered all his adult life from emotional and psychological problems?

Mr T went to his GP with the letter and soon after was diagnosed with Klinefelters syndrome, a genetic condition in which a man is born with an extra X chromosome. The main treatment is testosterone replacement therapy. This was also the treatment in 1968, contrary to what the surgeon told the GP in his letter.

Over the next 50 years, Mr T visited his GP practice about 350 times with all sorts of complaints from palpitations to anxiety. Several doctors expressly referred to the suspected Klinefelters in their notes but not a single one told him about this. No one referred him to an endocrinologist or a geneticist.

For example, in 1986 his exasperated GP referred him to a psychiatrist, writing in the referral letter:

It is totally impossible to make head or tail of his symptoms, which are obviously aggravated by anxiety and depression if not caused by them.

The only clue I have to this awful mess is that in 1968 he was found to be probably Klinefelters. Do you think this is the underlying problem?

Last year, Mr T started on hormone replacement therapy and he is a completely changed man. The effectiveness of the treatment in his 60s strongly suggests that it would also have been effective in his teenage years.

Osler would not have known about Klinefelters, which was only characterised and understood in the 1950s, but Oslers writings do have something to say about this story.

The head and the heart

As part of my preparation for this lecture, I read and re-read many of Oslers essays. One dominant theme in his writing is the importance for doctors of the head and the heart. For example:

The Army Surgeon, 1894

an art engaging equally heart and head

Teaching and Thinking, 1895

The physician needs a clear head and a kind heart; his work is arduous and complex, requiring the exercise of the very highest faculties of the mind, while constantly appealing to the emotions and finer feelings.

The Master-Word in Medicine, 1903

The practice of medicine is an art, not a trade; a calling, not a business; a calling in which your heart will be exercised equally with your head.

Ethicists have tended to focus on the importance of the heart, of compassion and kindness. In Mr Ts case, the surgeon in 1968 had his heart in the right place since he did not want to cause the patient or his parents needless worry about an untreatable condition, but the surgeon made a dreadful mistake of the head. He mistakenly informed the GP that there was no treatment for Klinefelters. There was, and there is little doubt that Mr Ts life would have been radically different had he been treated then.

In Teacher and Student (1892), Osler wrote of the importance of the Quality of Thoroughness:

It means such a knowledge of diseases and of the emergencies of life and of the means for their alleviation, that you are safe and trustworthy guides for your fellowmen.

That does not mean, of course, that a general surgeon should know about Klinefelters syndrome but that he or she should either look things up or follow Oslers advice when he said:

I have learned since to be a better student, and to be ready to say to my fellow students I do not know.

That surgical registrar in 1968 could have just told the GP that he does not know about the management of Klinefelters. That would have led the GP to refer Mr T to a specialist.

Instead, the registrar on this occasion failed to be a safe and trustworthy guide to his GP colleague, with tragic, life-long consequences for his patient.

The Hippocratic Oath

A big clue about Oslers ethics lies in his admiration for the Hippocratic Oath. In Chauvinism in Medicine (1902), he writes of the high moral ideals, expressed in that most memorable of human documents, the Hippocratic oath.

In an unpublished lecture in 1910 on The Lessons of Greek Medicine, he called the oath the credo of the profession.

In my role as an ethicist, I deliver one to one ethics training to doctors who have been accused or found guilty of misconduct by their employer or their regulatory body. Whatever they did wrong, whether its a mistake of the head or the heart, I always start the course by looking at the Hippocratic Oath, which is only about 400 words long but contains the essence of medical ethics. One passage reads:

I will not cut persons labouring under the stone but will leave this to be done by men who are practitioners of this work.

My interpretation of this is that doctors should know the limits of their competence and refer to suitable colleagues when something falls outside their own limits. Only then can they truly benefit the ill and keep them from harm, which are other instructions in the Oath.

Interestingly, in the case of Mr T, its not the medic who needs to refer the patient to the surgeon but the surgeon who needs to refer to the medic!

The modern version of the Oath might read:

I will not make recommendations about treatments for conditions outside my field of expertise but will leave this to be done by men or women who are practitioners in that field.

Speaking out

In the 1970s, 80s, 90s and 2000s, Mr Ts doctors had opportunities to tell him about the suspected diagnosis made in 1968. Several of them had spotted the letter from the surgical registrar, dated 20th Aug 1968. Yet, none of them said anything to Mr T.

I have asked myself and others why they withheld this from him. Part of the answer must be that the doctors were reluctant to open the proverbial can of worms, especially in a 10 minute consultation. After all, they might have received a complaint or even got sued by the patient. It was much easier to maintain the status quo.

There are two helpful lessons from Osler here.

The first is his emphasis on the golden rule.

In Chauvinism in Medicine (1902), he wrote the golden rule is not always, as it should be, our code of ethics (emphasis added).

In Nurse and Patient (1897):

In some of us the ceaseless panorama of suffering tends to dull that fine edge of sympathy with which we started. [] we physicians and nurses have but one enduring corrective the practice towards patients of the Golden Rule of Humanity as announced by Confucius: What you do not like when done to yourself, do not do to others

I suspect most of us, if we applied the golden rule to Mr Ts situation, would have wanted to know the truth, or at least been given the option of knowing the truth.

Now, an awareness of the Golden Rule does not mean that people will actually apply it, especially when it could lead to an awkward or unpleasant situation. This is where the second lesson from Osler comes in.

The second lesson is the importance of moral courage, so prevalent in Aequanimitas (1889). Referring to the cares and anxieties incident to professional life, Osler writes Stand up bravely, even against the worst and continues if the fight is for principle and justice, even when failure seems certain, where many have failed before, cling to your ideal, and, like Childe Roland before the dark tower, set the slug-horn to your lips, blow the challenge, and calmly await the conflict.

It is not enough to think ethically, to have virtuous thoughts, but you must also act ethically and this at times will require a great deal of moral courage. I suspect some of Mr Ts doctors knew that giving Mr T the option of knowing the truth about his condition was the morally right course of action. Nonetheless, for whatever reason, they failed to act on this knowledge.

In his book Disrupted Dialogue, the American bioethicist Robert Veatch dismissed Oslers philosophy as pop-philosophy and more recently Fiddes and Komesaroff have called for a reappraisal of Oslers legacy, criticising Osler for, among other things, avoid[ing] the debates concerning medical ethics.

My response is that Osler never claimed to be a philosopher, in fact quite the opposite. In Science and Immortality (1904), he wrote:

Neither a philosopher nor the son of a philosopher, I miss the lofty vantage-ground of a prolonged training in things of the spirit enjoyed by my predecessors in this lectureship.

Osler certainly did not avoid discussing the ethics of his profession, even though he rarely used the word ethics in his writings. In fact, I would argue that a significant part of his work is about ethics, about the fundamentally moral nature of medicine, about that special bond between doctor and patient and between doctors themselves, about the importance of a doctors character, about moral ideals, the virtues of the head and heart, such as wisdom, patience, coolness of nerve, courage in the face of injustice, respect for patients and colleagues, humility, kindness and good judgement. These lessons about being a doctor and the practice of medicine, like so many of the classical texts quoted by Osler, transcend time. Surely that is why, 100 years on from his death, we still write and talk about Osler and still apply his advice to contemporary cases, like that of Mr T.

When I last saw Mr T, he had a beard. It was the first time in his life he had been able to grow any facial hair. He was also in a happy relationship.

A few months ago, we obtained a large settlement in compensation for Mr Ts losses over the last 50 years.

Daniel Sokolis a medical ethicist and barrister at 12 Kings Bench Walk, London. He is the author of Tough Choices: Stories from the Front Line of Medical EthicsBook Guild, 2018).Twitter:@danielsokol9

Competing interests: None declared.

Patient consent was obtained for the content of this article.

See the rest here:
Daniel Sokol on William Osler's legacy and medical ethics - The BMJ - The BMJ

The Male Hypogonadism Market To Slither Amidst Covid-19, To Pick Up Pace Post-Covid-19, Reach US$ 3300 Mn – The Think Curiouser

Market Report Summary

For Full Information -> Click Here

Read Full Press Release Below

According to Persistence Market Researchs new report, globalmale hypogonadism marketis slated to exhibit a steady expansion throughout the forecast period (2017-2026). Revenues from the global market for male hypogonadism are estimated to exceed US$ 3,300 Mn by 2026-end.

Governments Taking Initiatives to Spread Awareness about Male Hypogonadism Therapeutics

Lack of sex hormones, usually referred to as male hypogonadism has resulted into many health risks that include osteoporosis, heart disease, and cardiovascular diseases on the back of thinning of bones. Global male hypogonadism market comprises several patented brands that currently have high market penetration. Proliferation in geriatric population in tandem with rising incidences related to rheumatoid arthritis and obesity have been primary factors affecting prevalence of male hypogonadism globally.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/22303

Company Profiles

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/22303

Mounting incidences of testosterone deficiency in male population is a key factor that prevalence of male hypogonadism has surged worldwide. Several governments around the world have been taking initiatives to spread the awareness on hypogonadism treatment procedures, for example testosterone replacement therapy (TST), in order to relieve the painful burden on patients and their families.

As low testosterone levels are increasingly associated with exacerbation of chronic conditions, it further results into disorders apropos to hypothalamic-pituitary-gonadal axis. Advent of TST has however enabled reduction in cases of male hypogonadism considerably. With growing awareness related to its treatment among patients, the market is likely to gain an uptick during the forecast period.

Rising availability of the selective androgen receptor modulators (SARMs) has further sustained the market expansion. The development and high availability of SARMs has led toward the provision of improved treatment procedure to patients having androgen deficiencies, thereby influencing the market growth.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/22303

North America will continue to Dominate Global Male Hypogonadism Market

North America will continue to dominate the global male hypogonadism market, with more than one-third revenue share during the forecast period. In addition, revenues from the male hypogonadism market in North America will exhibit the fastest expansion through 2026, as compared to those from all the other regional segments comprised in the report. Europe and Asia-Pacific excluding Japan (APEJ) are also expected to remain lucrative for the male hypogonadism market. The market in APEJ will ride on a slightly higher CAGR than that in Europe through 2026.

Topical gels are expected to remain the most lucrative among drugs available for treatment of male hypogonadism globally, with sales projected to register the fastest expansion through 2026. Injectables will also remain a major revenue contributor to the market. Sales of injectable and transdermal patches are poised to reflect an equal CAGR through 2026.

Testosterone Replacement Therapy to Remain Preferred among Patients

Based on therapy, testosterone replacement therapy is expected to remain preferred among patients with male hypogonadism worldwide. Roughly 66% revenue share of the market is expected to be held by revenues from testosterone replacement therapy by 2026-end. Revenues from gonadotropin replacement therapy will remain slightly more than half revenues gained from testosterone replacement therapy throughout the forecast period.

Klinefelters syndrome is expected to remain the most prevalent disease type observed in the male hypogonadism market, and revenues from treatment of this disease will exceed US$ 1,800 Mn by 2026-end. Kallmann Syndrome and Pituitary Adenomas among disease types will also account for major revenue shares of the market by 2026-end.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website https://www.persistencemarketresearch.com

Go here to read the rest:
The Male Hypogonadism Market To Slither Amidst Covid-19, To Pick Up Pace Post-Covid-19, Reach US$ 3300 Mn - The Think Curiouser

Rise of veganism – The Lake Front

As Veganism grows in popularity, how has that impacted American society?

San Antonio, TX Veganism, a lifestyle that involves avoiding the consumption and use of animal products, has become mainstream in American culture. according to Dr. Alexander Hutchison, Our Lady of the lake University (OLLU) assistant professor of kinesiology, the vast majority of people who are going to be on a vegan diet are either going to do it for what they perceive being health benefits or moral objections to either killing animals or just animal husbandry in general.

Even though this diet does not contain animal products, a vegan diet is just as healthy as any other diet. Having a diversified meal with different plant products is key.

According to Hutchison, veganism is a modern construct of the last 20 years, The really strict vegan lifestyle, that was really not around in popular culture until I dont remember it until the 90s, and then moving forward from there.

Vegan Menu

With greater demand for vegan menu options, the supply at fast-food restaurants has also increased. According to People for the Ethical Treatment of Animals (PETA) restaurants such as Burger King, White Castle, Freddys, and TGI Fridays, have all introduced plant-based vegan-friendly menu options.

When Burger King launched the Impossible Whopper nationwide in 2019, they claimed it would taste similar to a real Whopper. Catherine Brooks, a University of Texas at San Antonio (UTSA) Business Management student, has recently begun eating vegan food. In her opinion the Impossible Whopper does taste similar to real meat, Ive had my friends try it, my boyfriend try it, and they say its close if not you wouldnt really be able to tell a difference.

Does vegan mean healthy?

One important distinction to keep in mind is that plant-based food does not always equal healthy food. Many fast food choices today are processed meals. The U.S. Department of Agriculture (USDA) defines processed food as one that has undergone any changes to its natural state Ultra-processed food is sometimes not considered real food because of how much its been modified.

According to Hutchison, now you completely defeated the purpose of going to a vegan diet which is to eat raw foods. Youre now eating something that is vegan but its not healthy cause youve now taken beets and processed them into something thats not food anymore.

Brooks agrees but states, its not really even healthy for you but I think the main point of meats substitutes is its supposed to be a substitute, its not supposed to be something that youre eating to promote your health.

Although meals might not be healthier, the presence of plant-based foods emerging in the fast-food world is promising.

As more restaurants begin to cater to vegan-friendly food, will you change your diet?

Like Loading...

Related

More:
Rise of veganism - The Lake Front

The History of Veganism Around the World – LIVEKINDLY

Around the world, people are eating more meat-free and vegan food than ever before.

But vegan food is not just a modern invention, and meat-free diets are not dependent on cutting-edge alternatives. Some anthropologists believe that early humans mostly gathered and ate plants. They supplemented a primarily plant-based diet with occasional animal protein and meat. Studies on the Paleolithic or Stone Age diet reveal that early humans collected up to 55 different types of plants to eat and relied heavily on vegetarian foods for nutrition and survival.

Prior to the foundation of The Vegetarian Society (VegSoc) in 1847, the word vegetarian itself was not widely used. It was not until the 1960s that a meat-free diet became popular in the U.S. and UK. But meat-free diets were and are present in a variety of forms in different countries around the world prior to this.

The history of plant-based food does not belong to Western countries. And in some regions, plant-based food has been present for thousands of years. Each nation has its own unique version of a meat-free diet, with its own history, influences, go-to ingredients, and delicious national dishes.

Many followers of Ancient Dharmic traditions such as Hinduism, Jainism, Buddhism, and Sikhism, along with some followers of Abrahamic religions such as Islam, Judaism, and Christianity, adhere to a meat-free lifestyle as part of their religious doctrine. Because of this, the history and development of religions frequently shaped national attitudes to meat consumption.

Vegan cuisine and vegetarian culture are found in many countries around the world. It is frequently deeply rooted in tradition, religious beliefs, and cultural landmarks. More than a modern trend, a Western lifestyle, or a youthful fad, following a plant-based lifestyle can be a deeply personal choice with myriad complex connotations.

The following countries have either a history of veganism and meat-free foods, an ongoing plant-based movement, or an up-and-coming vegan demographic.

The earliest record of vegetarianism dates back to 5th Century BCE India. The ancient religion of Jainism promotes a meat-free diet. Jain vegetarianism is one of the most strict and rigorous religiously motivated diets on the Indian subcontinent. Hinduism and Buddhism also incorporate a vegetarian diet and originate in approximately 1500 BC and the 5th century, respectively.

In Indian culture, the practice of nonviolence, or ahis, has informed meat-free living. It is present in Jainism, Hinduism, and Buddhism. The idea that all living beings, including animals, have a spark of divine energy in them inspires the concept of ahis. According to Jainism, the universality of divine energy means that to hurt others is to hurt oneself.

According to government surveys, approximately 23-37 percent of the Indian population is vegetarian today. However, some experts believe that cultural and societal pressure may lead to the under-reporting of meat consumption.

Research from India-based economist Suraj Jacob and U.S.-based anthropologist Balmurli Natrajan indicates that just 20 percent of the Indian population is actually vegetariana much lower percentage than government data would suggest.

Some people associate vegetarianism with social conservatism and restrictive, religious tradition. While eating meat can be seen as liberal and modern. But as national attitudes towards meat and animal products fluctuate, there is also an increased demand for modern vegan products.

Experts hypothesize that an increase in the use of social media has led to more awareness of the ethical and sustainability issues surrounding meat. As in other countries, this awareness can be found primarily in young people.

According to ABC, approximately 50 million Chinese people follow a vegetarian diet todayless than four percent of the total population. But plant-based foods are still an integral part of the national cuisine, including both tofuwhich has been consumed in China for more than 2,000 yearsand vegetarian meat.

According to the online tour operator China Highlights, the majority of Chinese vegetarians are meat-free because of their religious beliefs. Approximately half of the worlds Buddhists live in China, making up around 18 percent of the total population. Buddhists monks and nuns, in particular, tend to follow a strict vegetarian diet. They frequently exclude animal products such as eggs and dairy, too.

Buddhism, in general, has had a significant impact on Chinese cuisine. It has also informed regional dishes from other East Asian countries such as Korea, Cambodia, and Thailand. In China, the number of Buddhist, vegetarian restaurants has increased year-on-year. The vegetarian meat industry is still growingpartly thanks to the Buddhist population.

In 2019, Shanghai held its first plant-based meat festival, including both domestic and foreign producers and products. According to the plant-based advocacy group the Good Food Institute (GFI), the plant-based meat market in China has grown by 14.3 percent per year since 2014.

Beyond Meat recently opened a major production facility in China, while Green Mondays OmniPork is available at Aldi supermarkets nationwide. Experts estimate that the Chinese vegan food market could be worth nearly $12 billion USD by the year 2023.

Plant-based foods are an integral part of Japanese cuisine, too. While being fully vegan can be a challenge in some regions, meat-free staples such as tofu play a key role within Japans food-centered culture. In the Japanese archipelago of Okinawa, plant-based foods make up the vast majority of the traditional diet. Though as an island country, Japans national and regional cuisine historically includes a significant amount of seafood and fish.

With the introduction of Buddhism to Japan around the 6th Century, eating meat became taboo due to the First and Fifth Moral Precepts; the prohibition of the killing of animals, and the classification of meat as a bodily toxin. The Five Moral precepts are central to many Buddhists moral philosophy, and the staple diet of Buddhist monksShojin Ryoriis vegan by default.

Because of veganisms association with strict religious scripture, it didnt catch on as a trend or lifestyle in the same way it has in other countries. But today, most major cities and towns offer vegan options, and there are frequently vegetarian restaurants near to Buddhist temples.

In December 2019, a fully vegan supermarket opened near Asakusa Station in Tokyo. While the plant-based meat market continues to grow. According to the Japanese Tourism Agency, approximately four percent of Japan is vegetarian.

Popular national dishes such as fermented soybeans, or natto, are naturally plant-based and particularly healthy. Fermented soy is high in protein and contains vitamins, minerals, and probiotics. Other foods and ingredients, including miso, soba, and udon noodles, umeboshi, vegetarian ramen, and even the glutinous rice-based dessert, mochi, are frequently vegan-friendly.

Vegetarianism has a long history, and Ancient Greek philosophy includes explicit references to animal advocacy. Before the word vegetarian was popularized, living without meat was often described as the Pythagorean Diet.

Pythagoras, a philosopher and mathematician, believed a vegetarian diet was healthy for both body and mind.

Pythagoras also believe that all living beingsincluding animalshad souls and could experience suffering. Because of this, and because he believed that a vegetarian diet was optimal for humans, Pythagoras claimed that eating animals was unnecessary, and therefore indefensible. Many of his followers, Pythagoreans, also followed a meat-free vegetarian diet.

In more recent years, and as meat consumption increased overall in Greece, it remained a primarily luxury item reserved for the wealthy. This was largely due to the prohibitive cost of raising animals for food. Instead, fruit, vegetables, and other nutritious foods made up the bulk of the traditional Greek diet, much as they do now.

Many nutrition and health experts highlight the Mediterranean diet as one of the healthiest. It primarily emphasizes plant-foods alongside small quantities of animal products, particularly fresh fish and seafood. Globally, meat remains a luxury item for many rural and low-income communities.

The Greek population that follows a strict plant-based diet are those between the ages of 18 to 24, a trend mirrored in millennial and younger demographics around the world.

Jamaica is the birthplace of Rastafari, a religious and social movement that has since spread around the world. Most followers of Rastafarianism follow dietary restrictions outlined in the biblical Book of Leviticus, avoiding both crustaceans and pork.

But many Rastas follow entirely vegetarian or vegan diets, also based on Leviticus, along with the influence of Indian dishes on the national cuisine. Much like the religious diets of Jains, Hindus, and Buddhists, some consider Rastafarian Ital as a proto-vegan diet.

The Rastafarian dietknown as Ital, derived from vitalemphasizes natural, frequently local, and organically produced foods. To a certain extent, Rastas have also commercialized the ital diet. Dishes, drinks, and smoothies prepared to Ital specifications are widely available.

Overall, followers of Ital believe it increases liveliness and life energy. Traditional Jamaican Ital dishes include one-pot stews incorporating local, seasonal produce. Thanks to the tropical climate, fresh fruit and vegetables are plentiful, and Jamaican cuisine, in general, reflects this.

In recent years, Israel has secured its place as the leading vegan country in the world. Vegans now make up more than five percent of the population. Tel Aviv, in particular, features world-renowned vegan restaurants. More than 400 restaurants in the populous city are widely considered to be vegan-friendly.

Some Israeli vegan advocates note that for those who keep kosher, checking ingredients and thinking about what you eat, in general, is familiar. Eating from the land, both seasonally and locally, is at the heart of Israels national cuisine.

Much of Israels traditional dishes emphasize fresh vegetables, fruit, and pulses. And dishes such as couscous, houmous, falafel, aubergine-based baba ganoush, and stuffed vine leavesor domaare all frequently cited as vegetarian staples.

In Dimona, Israel, the all-vegan Village of Peace has been eating plant-based food for the last 50 years. Located in the Neve Shalom compound, the Village of Peace is home to a religious community called the African Israelites of Jerusalem. While not Jewish, the members consider themselves the spiritual descendants of ancient Israelites.

The group helped to popularise vegan food nationally. They even opened their own factory to produce soy milk, tofu, and other staples at a time when alternatives were unavailable. This factory supplied the cheese used in Dominos first-ever vegan pizza trial back in 2015exclusively in Israel.

Interest in vegetarianism and veganism has doubled in the last decade, and plant-based food is now more mainstream than ever.

Read the rest here:
The History of Veganism Around the World - LIVEKINDLY

Veganism as a dietary preference The Manila Times – The Manila Times

By definition, veganism (in food) is the avoidance of meat and its by products in ones nutritional diet. It was coined by Donald Watson back in 1944. A piece of trivia: did you know that aside from November 1 being commemorated as All Saints Day, it is also celebrated as World Vegan Day? This day gathers vegans all over the world to celebrate this day through various festivities and activities.

The scope of veganism is far and wide, and can be political, however it is not the intention of this article to cover that. Rather, the objective is to create the awareness for such practice, and to emphasize how living in a tropical country like the Philippines could enable any vegan-curious individual to start exploring our available resources in order to sustain a vegan lifestyle.

Globally, approximately two percent of the population is vegan. Vegans, or plant-based eaters, as the name implies, consume non-animal products. The diet is mostly centered on fruit and vegetables, and other plant-based protein sources such as lentils, beans, soy, to name a few. To the uninitiated, this could be quite shocking considering how Filipinos are used to consuming meat and dairy. However, in the recent years, veganism has somehow gotten mainstream, so much so that you would now see vegan products available in the grocery stores. You now have vegan choices available for milk and cheese, as an example.

My journey to being vegan started as early as 2015 when, while being pescatarian for 2 years back then I decided to transition to vegan but unfortunately, I only lasted 2 weeks. In 2019, I decided to switch cold turkey and have not looked back since. In fact, it will be my first year this month.

The journey has not exactly been easy. I remember the first day I decided to switch to vegan and I was in Cebu that particular day. I checked the menu in the hotel and the breakfast they have available is not vegan-friendly and so I had to request if they can make something for me, which they happily obliged. Nonetheless, the concept of vegan food was limited to salad, vegetables and other similar ingredients that the kitchen either sauted, boiled or roasted with minimal thinking on nutrition and creativity. It is not the case nowadays. In fact, there are too many options available now that one just has to look closely.

The interest in sustaining a vegan lifestyle in the Philippines even got more exciting when I discovered Maria Orosa, our greatest food technologist, that even during the war in the 40s we already had a thriving vegan lifestyle, just that it wasnt discovered yet or we did not know how to call it. Her recipes on corn, cassava and coconut are all vegan-friendly more or less, and at most a little bit of tweaking is only needed. The good thing is that with our country being rich in natural (and vegan) resources it should not be as difficult to look into this dietary preference.

The benefits of having a vegan dietary preference are enormous, and one would find a lot of information and literature on this online. For now, heres a vegan recipe that is easy and can be done very quickly if pressed for time.

Easy Broccoli Spaghettini

Broccoli Spaghettini

Ingredients:

2 heads broccoli, florets sliced3 cloves garlic, minced1 white onion, sliced1 teaspoon chilli flakesDash of salt and pepper1 teaspoon onion powder1/4 cup almond sliversOlive oil2 to 3 tablespoons of water450g spaghettini noodles

Procedure:

1. Cook noodles according to package instructions.

2. In a pan, heat olive oil. Saut garlic and onion. Once the onions are translucent, add the broccoli florets, a bit of water and the rest of the spices.

3. Test for seasoning and finally add noodles to the sauce and garnish with almond slivers.

Yield: Serves 4 to 6

Notes:

Send comments to kaycalpolugtu@gmail.com or follow @kaycalpolugtu and @aplateofbahaykubo.

Go here to see the original:
Veganism as a dietary preference The Manila Times - The Manila Times

Healthcare Nanotechnology (Nanomedicine) Market Statistics 2019: Top Impacting Factors That Can Win the Industry Worldwide – PRnews Leader

UPDATE AVAILABLE ON-DEMAND

Nanomedicine is an application of nanotechnology that deals in the prevention & treatment of diseases in humans. This technology uses submicrometer-sized particles for diagnosis, treatment, and prevention of diseases. Nanomedicines are advantageous over generic drugs in several aspects such as, to reduce renal excretion, improve the ability of drugs to accumulate at pathological sites, and enhance the therapeutic index of drugs. Thus, nanomedicine is used in a wide range of applications that include aerospace materials, cosmetics, and medicine.

The global nanomedicine market was valued at $111,912 million in 2016, and is projected to reach $261,063 million by 2023, growing at a CAGR of 12.6% from 2017 to 2023. The drug delivery segment accounted for nearly two-fifths share of the global market in 2016.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2021

The global market is driven by increase in the development of nanotechnology-based drugs, advantages of nanomedicine in various healthcare applications, and growth in need of therapies with fewer side effects. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth. In addition, growth of healthcare facilities in emerging economies is anticipated to provide numerous opportunities for the market growth.

The vaccines segment is expected to register a significant CAGR of 13.2% throughout the forecast period. The treatment segment accounted for about fourth-sevenths share in the global market in 2016, accounting for the highest share during the forecast period. This is due to the high demand for therapeutics among patient and rise in the incidence of chronic diseases.

The neurological diseases segment is expected to grow at the highest CAGR of 13.9% during the forecast period, owing to high demand for brain monitoring & treatment devices and drugs. The oncological diseases segment accounted for the highest revenue in 2016, with one-third share of the global market, and is expected to maintain its dominance throughout the forecast period.

In 2016, Asia-Pacific and LAMEA collectively accounted for about one-fourth share of the global market, and is expected to continue this trend due to increased adoption of nanomedicines, especially in China, India, and the other developing economies. In addition, rise in investments by key players in the field of nanomedicines is key driving factor of the Asia-Pacific market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2021

The Major Key Players Are:

The Other Prominent Players Are:

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of Market Research Reports and Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free (USA/Canada):+1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1-855-550-5975[emailprotected]Web:https://www.alliedmarketresearch.com

Read more:
Healthcare Nanotechnology (Nanomedicine) Market Statistics 2019: Top Impacting Factors That Can Win the Industry Worldwide - PRnews Leader

Healthcare Nanotechnology (Nanomedicine) Market Share, Segments by Size, Growth, Market Share, Types, Key Vendors with Development and Scope, Forecast…

Global Healthcare Nanotechnology (Nanomedicine) Market report provides a detailed analysis of market overview and trends, key segments, business strategies, developments of key players, the future outlook of the market. This research report gives comprehensive knowledge and valuable insights about the Healthcare Nanotechnology (Nanomedicine) market. The report contains an in-depth analysis of the market size, growth, opportunities, product types, and services. The market is expected to grow at a different CAGR value during the forecast period of 2018-2023.

The report offers an overview of revenue, market share, demand, restraints, and supply of data during the projected year. These factors are becoming increasingly important in the present scenario.

Get a Sample Copy of the Report at https://www.absolutereports.com/enquiry/request-sample/13102426

Top Key Manufactures of Healthcare Nanotechnology (Nanomedicine) Market:

Market Dynamics :

> Drivers Rising Incidence of Cardiovascular Diseases Increasing Research Funding Rising Awareness of Nanomedicine Application Increasing Applications in Oncology

> Restraints High Costs of Nanotechnology-Based Medical Devices Time-Consuming Product Approval

> Opportunities

> Key Challenges

Regional Analysis:

This Healthcare Nanotechnology (Nanomedicine) report analysis segmented by geography, market share and revenues, market size, technologies, growth rate and forecast period of the following regions are including:

United States, Canada, Mexico, United Kingdom, France, Germany, Italy, Spain, Rest of Europe, India, China, Japan, Australia, South Korea, Rest of APAC, GCC, South Africa, Rest of MEA, Brazil,Argentina, Rest of South Africa

The Healthcare Nanotechnology (Nanomedicine) market contains industry challenges, business expansion plans, competitive landscape, key development, and accurate country-wise volume analysis and region-wise market size analysis of the global market. This detailed assessment of the market will help the company increase efficiency.

Inquire or Share Your Questions If Any Before the Purchasing This Report https://www.absolutereports.com/enquiry/pre-order-enquiry/13102426

Key Developments in the Market::> Major developments in 2017 covered in the report> And the latest major developments in 2018 covered in the report

Key Reasons to Purchase this Report:

Purchase this Report (Price 4250 USD for a Single-User License) https://www.absolutereports.com/checkout/13102426

Detailed TOC of Global Healthcare Nanotechnology (Nanomedicine) Market Growth, Trends, Challenges and Forecast (2018 2023)

1 Healthcare Nanotechnology (Nanomedicine) Market Introduction

1.1 Study Deliverables

1.2 General Study Assumptions

2 Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Study Phases

2.4 Econometric Modelling

3 Executive Summary

4 Healthcare Nanotechnology (Nanomedicine) Market Overview and Trends

4.1 Introduction

4.2 Healthcare Nanotechnology (Nanomedicine) Market Trends

4.3 Porters Five Force Framework

Continued

For Detailed TOC https://www.absolutereports.com/TOC/13102426#TOC

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Global Flex Fuel Engine Market Status and Outlook: 2020 Business Development Plans by Companies, Industry Trends and Restraints, Market Share and Revenue till 2026

Global Smart Parking Sensors Market Status and Outlook: 2020 Business Development Plans by Companies, Industry Trends and Restraints, Market Share and Revenue till 2026

Global Electrical Enclosure Equipments Market Report Insights Forecast to 2020-2025, Market Segmentation, Impact of COVID-19 on Global Industry, Key Distributors/Retailers

Gift Cards Market 2020 Status and Outlook by Regions, Market opportunities, Market Challenges, Risk and Industry Trends, Manufacture Cost Structure

Veterinary Orthopedic Implants Market 2020 by Business Strategy, Development History, Types, Applications and Trends, Growth Factors by Regions, Market Size and Share till 2026

Global Food Packaging Technology and Equipment Market Demand Status 2020 Share, Global Market Trends, Current Industry News, Business Growth, Top Regions Update by Forecast to 2026

Medical & Lab Refrigerators Market Industry Growth and Demand, Product Overview, Company Profiles and Recent Business Development, Forecast to 2020-2026

Continue reading here:
Healthcare Nanotechnology (Nanomedicine) Market Share, Segments by Size, Growth, Market Share, Types, Key Vendors with Development and Scope, Forecast...

Augmenting Demand for Transfection Reagents And Equipment to Bolster Global Market Revenue Growth During 2020 – Eurowire

Transfection is a process that involves production of genetically modified cells with utilization of foreign nucleic acid (DNA and RNA). This technology helps the cells in mutation of cancer cells, protein metabolism by affecting the nuclear genes and regulation of gene therapy. Transfection is an integral equipment used in investigation studies for gene function and the modulation of gene expression. Thus, it contributes in the advancement of basic cellular research, drug discovery, and target validation. The transfection reagent and equipment market is driven by rising prevalence of infectious disease, utilization of biopharmaceuticals in the production of proteins, growing obese population, and increasing prevalence of cancer. Various government initiative accentuated the growth of transfection reagent and equipment market. However, high cost of transfection reagents and equipment, risk factors during insertion of the reagents and cytotoxic effect associated with transfection technology are the major factors restraining the transfection reagents and equipment market.

The transfection reagent and equipment market can be segmented on the basis of various methods such as physical methods and biochemical methods. The biochemical method accounts for the largest share in the overall transfection market. The biochemical based method is further segmented as calcium phosphate, DEAE-dextran, lipid mediated transfection (Lipofection), catonic polymers, activated dendrimers and magnetic beads. The physical based method includes electroporation, biolistic technology, microinjection, laserfection and others (gene gun, sonoporation). Electroporation technique is likely to account for the largest share in the equipment based transfection. The transfection reagent market, by application is segmented into biomedical research, protein product, and therapeutic delivery. The biomedical research segment was observed as one of the largest segment of the transfection reagent market.

To remain ahead of your competitors, request for a sample [emailprotected]

https://www.persistencemarketresearch.com/samples/6616

Geographically, North America is the largest transfection reagents and equipment market in the world due to rising prevalence of various cancers (such as cervical cancer, breast cancer, colon cancer, and prostate cancer). Moreover, rising demand for proteomics and genomics technology and upfront initiatives taken by government related to preventive healthcare have supported the growth of transfection reagents and equipment market in this region. Europe was the second largest market due to rising trend of utilization of targeted drug delivery, nanomedicine in diagnostics, clinical trials and drug development studies drive the demand of transfection reagents and equipment market. Asia-Pacific is observed to be an emerging market in transfection reagents and equipment market and is still in the initial stage. One of the important factors driving the growth of transfection reagent and equipment in the Asia-Pacific market is outsourcing of clinical trials to Asian countries by majority of the drug development companies. Moreover, development of in transfection technology, rise in demand of protein therapeutics, developing healthcare infrastructure in emerging markets such as India and China, and increasing demand from applied markets. Latin American countries such as Brazil and Mexico are the regions that have significant potential for growth due to emerging medical infrastructure, high disposable income and rising prevalence of infectious diseases. Transfection equipment and reagents market is in introductory stage especially in Latin American and African countries.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/6616

Some of the major players in the global transfection reagent and equipment market include Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Roche Holding AG (Switzerland), Qiagen N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and Maxcyte Inc.(U.S.) others.

You Can Request for TOC Here @

https://www.persistencemarketresearch.com/toc/6616

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws on its multi-disciplinary capabilities and high pedigree team of analysts to share data that precisely corresponds to clients business needs.

PMR stands committed to bringing more accuracy and speed to clients business decisions. From ready-to-purchase market research reports to customized research solutions, PMRs engagement models are highly flexible without compromising on its deep-seated research values.

Contact Us:

Sourabh KJ

305 Broadway

7th Floor

New York City, NY 10007

United States

USA Canada Toll-Free: 800-961-0353

Email: [emailprotected]

Web: https://www.persistencemarketresearch.com

View original post here:
Augmenting Demand for Transfection Reagents And Equipment to Bolster Global Market Revenue Growth During 2020 - Eurowire